Skip to main content
Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Publisher: Bentham Science Publishers

More about this publication?
Volume 12, Number 3, 2005

Review article

Management of Bladder, Prostatic and Pelvic Floor Disorders with Botulinum Neurotoxin
pp. 247-265(19)
Authors: Maria, G.; Cadeddu, F.; Brisinda, D.; Brandara, F.; Brisinda, G.

Favourites:
ADD

Role of Nitrosative Stress and Peroxynitrite in the Pathogenesis of Diabetic Complications. Emerging New Therapeutical Strategies
pp. 267-275(9)
Authors: Pacher, Pal; Obrosova, Irina G.; Mabley, Jon G.; Szabo, Csaba

Favourites:
ADD

Novel Biological Agents for the Treatment of Hormone-Refractory Prostate Cancer (HRPC)
pp. 277-296(20)
Authors: Papatsoris, A. G.; Karamouzis, M. V.; Papavassiliou, A. G.

Favourites:
ADD

Chemotherapy of Breast Cancer in the Elderly
pp. 297-310(14)
Authors: Rossi, A.; Colantuoni, G.; Maione, P.; Ferrara, C.; Airoma, G.; Barzelloni, M. L.; Castaldo, V.; Gridelli, C.

Favourites:
ADD

Structure and Regulation of the Drug-Metabolizing Enzymes Arylamine N-acetyltransferases
pp. 311-318(8)
Authors: Dupret, Jean-Marie; Rodrigues-Lima, Fernando

Favourites:
ADD

Recent Advances in Pretargeted Radioimmunotherapy
pp. 319-338(20)
Authors: Gruaz-Guyon, A.; Raguin, O.; Barbet, J.

Favourites:
ADD

Matrix Metalloproteinase Inhibitors: A Review on Pharmacophore Mapping and (Q)Sars Results
pp. 339-355(17)
Authors: Kontogiorgis, C. A.; Papaioannou, P.; Hadjipavlou-Litina, D. J.

Favourites:
ADD
Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content